| Follow-up consultation with GPc | Follow-up consultation with GP and/or MHNd | Antidepressant drug | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Netherlands (Norway = reference) | Crude IRR | 95% CI | Adj IRRe | 95% CI | Crude IRR | 95% CI | Adj IRRe | 95% CI | Crude HR | 95% CI | Adj HRd | 95% CI |
All patients | 0.72 | 0.71–0.74 | 0.73 | 0.71–0.74 | 0.99 | 0.97–1.01 | 1.00 | 0.98–1.01 | 1.41 | 1.39–1.43 | 1.32 | 1.30–1.34 |
Stratified for age group | ||||||||||||
 18–39 | 0.64 | 0.62–0.66 | 0.64 | 0.63–0.66 | 0.92 | 0.89–0.94 | 0.92 | 0.89–0.94 | 1.37 | 1.33–1.42 | 1.39 | 1.34–1.43 |
 40–59 | 0.71 | 0.69–0.73 | 0.71 | 0.69–0.73 | 0.98 | 0.95–1.01 | 0.98 | 0.95–1.01 | 1.50 | 1.46–1.53 | 1.50 | 1.46–1.53 |
 60 +  | 0.95 | 0.91–0.98 | 0.95 | 0.92–0.99 | 1.20 | 1.15–1.25 | 1.21 | 1.16–1.26 | 1.11 | 1.07–1.14 | 1.10 | 1.07–1.14 |